Company Filing History:
Years Active: 2008-2012
Title: Michael Joseph Coghlan: Innovator in Pharmaceutical Development
Introduction
Michael Joseph Coghlan is a notable inventor based in Fishers, Indiana, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, Coghlan has focused on developing innovative treatments for inflammatory and immune disorders. His work is particularly relevant in the context of rheumatoid arthritis, showcasing his commitment to improving patient outcomes.
Latest Patents
Coghlan's latest patents include a groundbreaking glucocorticoid receptor modulator designed for the treatment of rheumatoid arthritis. The first patent details a compound known as (E)-N-{3-[1-(8-fluoro-11H-10-OXA-1-AZA-dibenzo [A,D] cyclohepten-5ylidene)-propyl]-phenyl}-methanesulfonamide, which is presented as a pharmaceutical composition. This invention provides methods for treating inflammatory and immune disorders by administering an effective amount of the compound or its pharmaceutically acceptable salt. The second patent also focuses on a glucocorticoid receptor modulator, emphasizing the importance of this compound in therapeutic applications.
Career Highlights
Coghlan is currently employed at Eli Lilly and Company, a leading global pharmaceutical company known for its innovative research and development. His role at Eli Lilly allows him to collaborate with other experts in the field and contribute to the advancement of medical science.
Collaborations
Throughout his career, Coghlan has worked alongside talented colleagues, including Jonathan Edward Green and Prabhakar Kondaji Jadhav. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical solutions.
Conclusion
Michael Joseph Coghlan's contributions to pharmaceutical innovation, particularly in the treatment of inflammatory and immune disorders, highlight his role as a key inventor in the industry. His work continues to impact the lives of patients, demonstrating the importance of research and development in healthcare.